In summary, the majority of studies using human tissues demonstrate upregulation of lipid metabolism including de novo lipogenesis and AA metabolism in polyps driven by mutations in APC, suggesting that these pathways can be the major contributors to CRC development and metabolic vulnerabilities during CRC initiation. This evidence concerns the gene APC and colorectal carcinoma.